BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Kodak
KODK
$486M
| $52.3K | ﹤0.01% |
7,964
-4,643
| -37% | -$30.5K |
|
|
LENZ
3402
LENZ Therapeutics
LENZ
$1.18B
| $51.6K | ﹤0.01% |
1,789
-859
| -32% | -$24.8K |
|
|
SEPN
3403
Septerna, Inc. Common Stock
SEPN
$637M
| $51.5K | ﹤0.01% |
+2,251
| New | +$51.5K |
|
3404
Ribbon Communications
RBBN
$676M
| $51.5K | ﹤0.01% |
12,383
-7,009
| -36% | -$29.2K |
|
|
MESO
3405
Mesoblast
MESO
$1.9B
| $51.5K | ﹤0.01% |
2,600
+2,597
| +86,567% | +$51.4K |
|
|
LGF.B
3406
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $51.4K | ﹤0.01% |
6,806
-947
| -12% | -$7.15K |
|
3407
Quantum-Si Incorporated
QSI
$239M
| $51.4K | ﹤0.01% |
+19,025
| New | +$51.4K |
|
3408
UroGen Pharma
URGN
$869M
| $51.1K | ﹤0.01% |
4,801
-3,745
| -44% | -$39.9K |
|
3409
IAMGOLD
IAG
$6.42B
| $51.1K | ﹤0.01% |
9,899
-1,511,771
| -99% | -$7.8M |
|
3410
Distribution Solutions Group
DSGR
$1.44B
| $51K | ﹤0.01% |
1,482
-3,532
| -70% | -$122K |
|
3411
Reservoir Media
RSVR
$517M
| $50.9K | ﹤0.01% |
+5,625
| New | +$50.9K |
|
3412
Vanguard Communication Services ETF
VOX
$5.89B
| $50.7K | ﹤0.01% |
327
+317
| +3,170% | +$49.1K |
|
3413
Lyra Therapeutics
LYRA
$10.3M
| $50.6K | ﹤0.01% |
+4,898
| New | +$50.6K |
|
3414
Inseego
INSG
$200M
| $50.5K | ﹤0.01% |
4,924
+3,549
| +258% | +$36.4K |
|
3415
Primis Financial Corp
FRST
$269M
| $50.5K | ﹤0.01% |
+4,332
| New | +$50.5K |
|
|
GRAL
3416
GRAIL, Inc. Common Stock
GRAL
$1.37B
| $50.3K | ﹤0.01% |
2,820
-26,214
| -90% | -$468K |
|
3417
Invesco Mortgage Capital
IVR
$502M
| $50.2K | ﹤0.01% |
+6,234
| New | +$50.2K |
|
3418
InflaRx
IFRX
$85.4M
| $50.1K | ﹤0.01% |
20,300
-3,000
| -13% | -$7.41K |
|
3419
Aura Biosciences
AURA
$384M
| $50.1K | ﹤0.01% |
+6,094
| New | +$50.1K |
|
|
VERV
3420
DELISTED
Verve Therapeutics
VERV
| $50.1K | ﹤0.01% |
+8,876
| New | +$50.1K |
|
3421
Tejon Ranch
TRC
$448M
| $50K | ﹤0.01% |
3,145
-1,270
| -29% | -$20.2K |
|
3422
Capricor Therapeutics
CAPR
$291M
| $50K | ﹤0.01% |
3,622
-14,077
| -80% | -$194K |
|
3423
Clean Energy Fuels
CLNE
$526M
| $49.8K | ﹤0.01% |
19,848
-17,376
| -47% | -$43.6K |
|
3424
Astria Therapeutics
ATXS
$419M
| $49.8K | ﹤0.01% |
+5,572
| New | +$49.8K |
|
3425
Kodiak Sciences
KOD
$489M
| $49.8K | ﹤0.01% |
5,004
-1,562
| -24% | -$15.5K |
|